EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine

Han Han, Bi-Te Chen, Yang Liu, Yi Wang, Lei Xing, Hui Wang, Tian-Jiao Zhou, Hu-Lin Jiang

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2023.12.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Han Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Regenerative Medicine, Cell Engineering. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 259 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stem cells have garnered significant attention in regenerative medicine owing to their abilities of multi-directional differentiation and self-renewal. Despite these encouraging results, the market for stem cell products yields limited, which is largely due to the challenges faced to the safety and viability of stem cells in vivo. Besides, the fate of cells re-infusion into the body unknown is also a major obstacle to stem cell therapy. Actually, both the functional protection and the fate tracking of stem cells are essential in tissue homeostasis, repair, and regeneration. Recent studies have utilized cell engineering techniques to modify stem cells for enhancing their treatment efficiency or imparting them with novel biological capabilities, in which advances demonstrate the immense potential of engineered cell therapy. In this review, we proposed that the "engineered stem cells" are expected to represent the next generation of stem cell therapies and reviewed recent progress in this area. We also discussed potential applications of engineered stem cells and highlighted the most common challenges that must be addressed. Overall, this review has important guiding significance for the future design of new paradigms of stem cell products to improve their therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicineCell EngineeringStem Cell TransplantationCell Differentiation

Stichwörter der Autor:innen

Genetically engineered stem cellsNano-engineered stem cellsStem cell drugsStem cell exosomesStem cell tracking

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China; College of Pharmacy, Yanbian University, Yanji 133002, China.
  • Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China. Electronic address: zhoutj1993@163.com.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China; College of Pharmacy, Yanbian University, Yanji 133002, China. Electronic address: jianghulin3@163.com.

Zitieren

APA

Han, H., Chen, B. T., Liu, Y., Wang, Y., Xing, L., Wang, H., Zhou, T. J., & Jiang, H. L. (2024). Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.12.024

Vancouver

Han H, Chen BT, Liu Y, Wang Y, Xing L, Wang H, et al. Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2023.12.024

BibTeX
@article{Han2024,
  author = {Han, Han and Chen, Bi-Te and Liu, Yang and Wang, Yi and Xing, Lei and Wang, Hui and Zhou, Tian-Jiao and Jiang, Hu-Lin},
  title = {Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2023.12.024}
}
Kostenlos starten →